Genome Editing Market - 2024-2033
The Genome Editing Market was valued at US$ 9.50 Billion in 2024 and is anticipated to reach US$ 37.22 Billion by 2033, at a CAGR of 0.165 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Genome Editing Market.
This report delivers a comprehensive overview of the Genome Editing Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Genome Editing Market. The Genome Editing Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.
Genome Editing Market Scope:
By Technology
This report delivers a comprehensive overview of the Genome Editing Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Genome Editing Market. The Genome Editing Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Genome Editing Market.
This report delivers a comprehensive overview of the Genome Editing Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Genome Editing Market. The Genome Editing Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.
Genome Editing Market Scope:
By Technology
- CRISPR/Cas9
- TALENs (Transcription Activator-Like Effector Nucleases)
- Zinc Finger Nucleases (ZFNs)
- Meganucleases
- Antisense Technologies
- Others
- Ex-vivo
- In-vivo
- Genetic Engineering
- Cell Line Engineering
- Animal Genetic Engineering
- Plant Genetic Engineering
- Drug Discovery & Development
- Gene-Modified Cell Therapy
- Diagnostics
- Others
- Biotechnology & Pharmaceutical Companies
- Academic & Government Research Institutes
- Contract Research Organizations (CROs)
- Thermo Fisher Scientific Inc
This report delivers a comprehensive overview of the Genome Editing Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Genome Editing Market. The Genome Editing Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Increase Your Customer Base by 3X using our Partner Identification tool
- Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
- Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
- Prioritize partners by strategic fit rather than general capability.
- Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
- Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
- White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
- Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
- Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
- Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS
3.1. Key Trends and Future Projections
4. SNIPPET BY TECHNOLOGY
4.1. Snippet by Delivery Method
4.2. Snippet by Application
4.3. Snippet by End User
4.4. Snippet by Region
5. DYNAMICS
5.1. Impacting Factors
5.1.1. Drivers
5.1.1.1. Increasing Prevalence of Genetic Disorders
5.1.1.2. Advancements in CRISPR and Other Technologies
5.1.1.3. Growing Investments in Genomic Research
5.1.2. Restraints
5.1.2.1. High Costs and Limited Accessibility
5.1.2.2. Ethical and Regulatory Challenges
5.1.2.3. Off-Target Effects and Safety Concerns
5.1.3. Opportunity
5.1.3.1. Integration of AI with Genome Editing
5.1.3.2. Growth in Agricultural Biotechnology
5.1.4. Impact Analysis
6. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
6.1. Market Leaders and Pioneers
6.1.1. Emerging Pioneers and Prominent Players
6.1.2. Established leaders with largest largest-selling Brand
6.1.3. Market leaders with established products & Services
6.2. Latest Developments and Breakthroughs
6.3. Regulatory and Reimbursement Landscape
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. South America
6.3.5. Middle East & Africa
6.4. Porter’s Five Force Analysis
6.5. Supply Chain Analysis
6.6. Patent Analysis
6.7. SWOT Analysis
6.8. Unmet Needs and Gaps
6.9. Recommended Strategies for Market Entry and Expansion
6.10. Pricing Analysis and Price Dynamics
7. BY TECHNOLOGY
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
7.1.2. Market Attractiveness Index, By Technology
7.2. CRISPR/Cas9*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. TALENs (Transcription Activator-Like Effector Nucleases)
7.4. Zinc Finger Nucleases (ZFNs)
7.5. Meganucleases
7.6. Antisense Technologies
7.7. Others
8. BY DELIVERY METHOD
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Method
8.1.2. Market Attractiveness Index, By Delivery Method
8.2. Ex-vivo*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. In-vivo
9. BY APPLICATION
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Genetic Engineering*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Cell Line Engineering
9.4. Animal Genetic Engineering
9.5. Plant Genetic Engineering
9.6. Drug Discovery & Development
9.7. Gene-Modified Cell Therapy
9.8. Diagnostics
9.9. Others
10. BY END USER
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Biotechnology & Pharmaceutical Companies*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Academic & Government Research Institutes
10.4. Contract Research Organizations (CROs)
11. GLOBAL GENOME EDITING MARKET REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.1.1. Market Attractiveness Index, By Region
11.1.2. North America
11.1.2.1. Introduction
11.1.2.2. Key Region-Specific Dynamics
11.1.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.1.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Method
11.1.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.1.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.1.2.7.1. U.S.
11.1.2.7.2. Canada
11.1.2.7.3. Mexico
11.1.3. Europe
11.1.3.1. Introduction
11.1.3.2. Key Region-Specific Dynamics
11.1.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.1.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Method
11.1.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.1.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.1.3.7.1. Germany
11.1.3.7.2. U.K.
11.1.3.7.3. France
11.1.3.7.4. Spain
11.1.3.7.5. Italy
11.1.3.7.6. Rest of Europe
11.1.4. South America
11.1.4.1. Introduction
11.1.4.2. Key Region-Specific Dynamics
11.1.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.1.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Method
11.1.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.1.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.1.4.7.1. Brazil
11.1.4.7.2. Argentina
11.1.4.7.3. Rest of South America
11.1.5. Asia-Pacific
11.1.5.1. Introduction
11.1.5.2. Key Region-Specific Dynamics
11.1.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.1.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Method
11.1.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.1.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.1.5.7.1. China
11.1.5.7.2. India
11.1.5.7.3. Japan
11.1.5.7.4. South Korea
11.1.5.7.5. Rest of Asia-Pacific
11.1.6. Middle East and Africa
11.1.6.1. Introduction
11.1.6.2. Key Region-Specific Dynamics
11.1.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.1.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Method
11.1.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.1.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
13. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS
13.1. Market Share Analysis and Positioning Matrix
13.2. Strategic Partnerships, Mergers & Acquisitions
13.3. Key Developments in Product Portfolios and Innovations
13.4. Company Benchmarking
14. COMPANY PROFILES
14.1. Thermo Fisher Scientific Inc*
14.1.1. Company Overview
14.1.2. Product Portfolio
14.1.2.1. Product Description
14.1.2.2. Product Key Performance Indicators (KPIs)
14.1.2.3. Historic and Forecasted Product Sales
14.1.2.4. Product Sales Volume
15. FINANCIAL OVERVIEW
15.1. Company Revenue
15.1.1. Geographical Revenue Shares
15.1.1.1. Revenue Forecasts
15.1.2. Key Developments
15.1.2.1. Mergers & Acquisitions
15.1.2.2. Key Product Development Activities
15.1.2.3. Regulatory Approvals, etc.
15.1.3. SWOT Analysis
15.2. Merck KGaA (Sigma-Aldrich)
15.3. CRISPR Therapeutics AG
15.4. Editas Medicine, Inc.
15.5. Cellectis S.A.
15.6. Precision BioSciences, Inc.
15.7. GenScript Biotech Corporation
15.8. Lonza Group Ltd.
15.9. New England Biolabs, Inc.
15.10. Integrated DNA Technologies, Inc. (IDT) (*LIST NOT EXHAUSTIVE)
16. ASSUMPTIONS AND RESEARCH METHODOLOGY
16.1. Data Collection Methods
16.2. Data Triangulation
16.3. Forecasting Techniques
16.4. Data Verification and Validation
17. APPENDIX
17.1. About Us and Services
17.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS
3.1. Key Trends and Future Projections
4. SNIPPET BY TECHNOLOGY
4.1. Snippet by Delivery Method
4.2. Snippet by Application
4.3. Snippet by End User
4.4. Snippet by Region
5. DYNAMICS
5.1. Impacting Factors
5.1.1. Drivers
5.1.1.1. Increasing Prevalence of Genetic Disorders
5.1.1.2. Advancements in CRISPR and Other Technologies
5.1.1.3. Growing Investments in Genomic Research
5.1.2. Restraints
5.1.2.1. High Costs and Limited Accessibility
5.1.2.2. Ethical and Regulatory Challenges
5.1.2.3. Off-Target Effects and Safety Concerns
5.1.3. Opportunity
5.1.3.1. Integration of AI with Genome Editing
5.1.3.2. Growth in Agricultural Biotechnology
5.1.4. Impact Analysis
6. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
6.1. Market Leaders and Pioneers
6.1.1. Emerging Pioneers and Prominent Players
6.1.2. Established leaders with largest largest-selling Brand
6.1.3. Market leaders with established products & Services
6.2. Latest Developments and Breakthroughs
6.3. Regulatory and Reimbursement Landscape
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. South America
6.3.5. Middle East & Africa
6.4. Porter’s Five Force Analysis
6.5. Supply Chain Analysis
6.6. Patent Analysis
6.7. SWOT Analysis
6.8. Unmet Needs and Gaps
6.9. Recommended Strategies for Market Entry and Expansion
6.10. Pricing Analysis and Price Dynamics
7. BY TECHNOLOGY
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
7.1.2. Market Attractiveness Index, By Technology
7.2. CRISPR/Cas9*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. TALENs (Transcription Activator-Like Effector Nucleases)
7.4. Zinc Finger Nucleases (ZFNs)
7.5. Meganucleases
7.6. Antisense Technologies
7.7. Others
8. BY DELIVERY METHOD
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Method
8.1.2. Market Attractiveness Index, By Delivery Method
8.2. Ex-vivo*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. In-vivo
9. BY APPLICATION
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Genetic Engineering*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Cell Line Engineering
9.4. Animal Genetic Engineering
9.5. Plant Genetic Engineering
9.6. Drug Discovery & Development
9.7. Gene-Modified Cell Therapy
9.8. Diagnostics
9.9. Others
10. BY END USER
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Biotechnology & Pharmaceutical Companies*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Academic & Government Research Institutes
10.4. Contract Research Organizations (CROs)
11. GLOBAL GENOME EDITING MARKET REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.1.1. Market Attractiveness Index, By Region
11.1.2. North America
11.1.2.1. Introduction
11.1.2.2. Key Region-Specific Dynamics
11.1.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.1.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Method
11.1.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.1.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.1.2.7.1. U.S.
11.1.2.7.2. Canada
11.1.2.7.3. Mexico
11.1.3. Europe
11.1.3.1. Introduction
11.1.3.2. Key Region-Specific Dynamics
11.1.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.1.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Method
11.1.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.1.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.1.3.7.1. Germany
11.1.3.7.2. U.K.
11.1.3.7.3. France
11.1.3.7.4. Spain
11.1.3.7.5. Italy
11.1.3.7.6. Rest of Europe
11.1.4. South America
11.1.4.1. Introduction
11.1.4.2. Key Region-Specific Dynamics
11.1.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.1.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Method
11.1.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.1.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.1.4.7.1. Brazil
11.1.4.7.2. Argentina
11.1.4.7.3. Rest of South America
11.1.5. Asia-Pacific
11.1.5.1. Introduction
11.1.5.2. Key Region-Specific Dynamics
11.1.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.1.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Method
11.1.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.1.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.1.5.7.1. China
11.1.5.7.2. India
11.1.5.7.3. Japan
11.1.5.7.4. South Korea
11.1.5.7.5. Rest of Asia-Pacific
11.1.6. Middle East and Africa
11.1.6.1. Introduction
11.1.6.2. Key Region-Specific Dynamics
11.1.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.1.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Method
11.1.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.1.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
13. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS
13.1. Market Share Analysis and Positioning Matrix
13.2. Strategic Partnerships, Mergers & Acquisitions
13.3. Key Developments in Product Portfolios and Innovations
13.4. Company Benchmarking
14. COMPANY PROFILES
14.1. Thermo Fisher Scientific Inc*
14.1.1. Company Overview
14.1.2. Product Portfolio
14.1.2.1. Product Description
14.1.2.2. Product Key Performance Indicators (KPIs)
14.1.2.3. Historic and Forecasted Product Sales
14.1.2.4. Product Sales Volume
15. FINANCIAL OVERVIEW
15.1. Company Revenue
15.1.1. Geographical Revenue Shares
15.1.1.1. Revenue Forecasts
15.1.2. Key Developments
15.1.2.1. Mergers & Acquisitions
15.1.2.2. Key Product Development Activities
15.1.2.3. Regulatory Approvals, etc.
15.1.3. SWOT Analysis
15.2. Merck KGaA (Sigma-Aldrich)
15.3. CRISPR Therapeutics AG
15.4. Editas Medicine, Inc.
15.5. Cellectis S.A.
15.6. Precision BioSciences, Inc.
15.7. GenScript Biotech Corporation
15.8. Lonza Group Ltd.
15.9. New England Biolabs, Inc.
15.10. Integrated DNA Technologies, Inc. (IDT) (*LIST NOT EXHAUSTIVE)
16. ASSUMPTIONS AND RESEARCH METHODOLOGY
16.1. Data Collection Methods
16.2. Data Triangulation
16.3. Forecasting Techniques
16.4. Data Verification and Validation
17. APPENDIX
17.1. About Us and Services
17.2. Contact Us
